02/12/2025
8:30 AM | FMR LLC (Filed by)
Regeneron Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
3:36 PM | Regeneron Pharmaceuticals (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
02/05/2025
8:18 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/04/2025
6:11 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
5:37 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
4:42 PM | Regeneron Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:01 PM | Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:01 PM | LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:02 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:02 PM | MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:02 PM | Pitofsky Jason (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for REGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
12/18/2024
3:02 PM | Regeneron Pharmaceuticals (Issuer)
STAHL NEIL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:03 PM | Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:38 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:33 PM | Regeneron Pharmaceuticals (Filer)
| Form S-3ASR | |
10/31/2024
6:16 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
6:10 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
6:00 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:01 PM | Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:01 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:01 PM | Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:27 PM | Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:35 PM | Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2024
4:55 PM | POON CHRISTINE A (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2024
10:45 AM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
3:53 PM | Regeneron Pharmaceuticals (Subject)
STAHL NEIL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:33 PM | Pitofsky Jason (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:40 PM | Pitofsky Jason (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
9:43 AM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:18 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
6:06 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
6:15 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/08/2024
6:00 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
3:01 PM | Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
4:24 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2024
3:39 PM | LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:41 PM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
1:46 PM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2024
3:01 PM | Regeneron Pharmaceuticals (Issuer)
SCHLEIFER LEONARD S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
4:04 PM | Regeneron Pharmaceuticals (Subject)
SCHLEIFER LEONARD S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
1:24 PM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Elon “obliterates” Bill Gates? (Ad) All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them Click here for my report |
06/03/2024
3:36 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
3:29 PM | BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024
4:57 PM | Regeneron Pharmaceuticals (Issuer)
SCHLEIFER LEONARD S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
5:10 PM | Regeneron Pharmaceuticals (Issuer)
SCHLEIFER LEONARD S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
3:16 PM | Regeneron Pharmaceuticals (Subject)
YANCOPOULOS GEORGE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024
3:21 PM | Regeneron Pharmaceuticals (Subject)
SCHLEIFER LEONARD S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
6:13 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
6:13 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
6:06 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
4:33 PM | Regeneron Pharmaceuticals (Subject)
RYAN ARTHUR F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2024
4:04 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2024
3:00 PM | Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
3:03 PM | Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
3:31 PM | MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:04 PM | Regeneron Pharmaceuticals (Issuer)
STAHL NEIL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:04 PM | Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:04 PM | LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
3:34 PM | LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
2:25 PM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
